Search Results 1251-1260 of 21911 for Inhibition

1. Risk-Based Therapy in Treating Younger Patients with Newly Diagnosed Liver Cancer - Mayo Clinic

   Patients must not be receiving any of the following potent cytochrome P450, family 3, subfamily A, polypeptide 4 (CYP3A4) inducers or inhibitors ...

2. Mayo Clinic Q and A: Lifestyle changes may ease laryngopharyngeal reflux

   Medications usually can reduce the symptoms of laryngopharyngeal reflux significantly. A class of drugs called proton pump inhibitors are typically the most ...

3. Topical Cryotherapy in Reducing Pain in Patients With Chemotherapy Induced Peripheral Neuropathy or Paclitaxel Induced Acute Pain Syndrome - Mayo Clinic

   ... inhibitors), at the entering Academic and Community Cancer Research United (ACCRU) institution; Life expectancy > 6 months; Eastern Cooperative Oncology Group ...

4. What is frontotemporal dementia? - Mayo Clinic News Network

   Loss of inhibition; Lack of interest (apathy), which can be mistaken for depression; Repetitive compulsive behavior, such as tapping, clapping or smacking ...

5. New hope for ovarian cancer Video Audio Vivien Williams

   PARP inhibitors block the protein from functioning, so cancer cells die. Andrea Wahner Hendrickson, M.D.. "Ovarian cancer is a tumor that, thankfully, does ...

6. Aspirin and omeprazole (oral route) - Mayo Clinic

   Omeprazole is a proton pump inhibitor (PPI). It works by decreasing the amount of acid produced by the stomach. This medicine is available only with your ...

7. A Study of JNJ-63723283, an Anti-programmed Death-1 Monoclonal Antibody, Administered in Combination With Daratumumab, Compared With Daratumumab Alone in Participants With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

   Have received at least 3 prior lines of therapy including a proteasome inhibitor (PI) and an immunomodulatory agent (IMiD) in any order during the course of ...

8. A Study to Evaluate Safety and Tolerability of Aducanumab in Participants With Alzheimer's Disease Who Had Previously Participated in the Aducanumab Studies - Mayo Clinic

   Use of chemotherapeutic agents and checkpoint inhibitors. Use of parenteral immunoglobulin, blood products, plasma derivatives, plasma exchange, or ...

9. Open-label, Single Arm Trial of BI 695502 in Patients With Previously Untreated Metastatic Colorectal Cancer - Mayo Clinic

   Prior therapy with monoclonal antibodies or small molecule inhibitors against Vascular endothelial growth factor (VEGF) or VEGF receptors, including Avastin® or ...

10. A Study to Compare the Effectiveness and Safety of JCAR017 to Standard of Care in Adult Subjects With High-risk, Transplant-eligible Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphomas - Mayo Clinic

    Immunosuppressive therapies within 4 weeks prior to unstimulated leukapheresis (e.g., calcineurin inhibitors, methotrexate or other chemotherapeutics ...